Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Modica

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 1, 2022
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine needle aspiration of neck paragangliomaAnna Maria Carillo, Raduan Ahmed Franca, Roberta Modica, et al.
Endocrine|April 22, 2015
Pituitary function and morphology in Fabry diseaseLuigi Maione, Fabio Tortora, Roberta Modica, et al.
Cancers|August 26, 2022
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, et al.
Frontiers in Endocrinology|May 8, 2023
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, et al.
Nutrients|April 12, 2020
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine TumorsBarbara Altieri, Carla Di Dato, Roberta Modica, et al.
Journal of Clinical Medicine|August 25, 2019
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine NeoplasmsSalvatore Tafuto, Claudia von Arx, Monica Capozzi, et al.
Endocrine|March 25, 2018
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept studyAntongiulio Faggiano, Roberta Modica, Rosa Severino, et al.
Endocrine|September 17, 2021
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumorsBarbara Altieri, Luigi Barrea, Roberta Modica, et al.
Neuroendocrinology|June 25, 2020
Pancreatic Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI SequencesFrancesco Verde, Roberta Galatola, Valeria Romeo, et al.
The Journal of Clinical Endocrinology and Metabolism|October 6, 2019
Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors < 2 CentimetersAntongiulio Faggiano, Roberta Modica, Fabio Lo Calzo, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 1, 2022
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine needle aspiration of neck paragangliomaAnna Maria Carillo, Raduan Ahmed Franca, Roberta Modica, et al.
Endocrine|April 22, 2015
Pituitary function and morphology in Fabry diseaseLuigi Maione, Fabio Tortora, Roberta Modica, et al.
Cancers|August 26, 2022
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, et al.
Frontiers in Endocrinology|May 8, 2023
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, et al.
Nutrients|April 12, 2020
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine TumorsBarbara Altieri, Carla Di Dato, Roberta Modica, et al.
Journal of Clinical Medicine|August 25, 2019
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine NeoplasmsSalvatore Tafuto, Claudia von Arx, Monica Capozzi, et al.
Endocrine|March 25, 2018
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept studyAntongiulio Faggiano, Roberta Modica, Rosa Severino, et al.
Endocrine|September 17, 2021
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumorsBarbara Altieri, Luigi Barrea, Roberta Modica, et al.
Neuroendocrinology|June 25, 2020
Pancreatic Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI SequencesFrancesco Verde, Roberta Galatola, Valeria Romeo, et al.
The Journal of Clinical Endocrinology and Metabolism|October 6, 2019
Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors < 2 CentimetersAntongiulio Faggiano, Roberta Modica, Fabio Lo Calzo, et al.
Pageof 7